Sandra Muñoz-Galván

1.3k total citations
40 papers, 1.0k citations indexed

About

Sandra Muñoz-Galván is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sandra Muñoz-Galván has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Sandra Muñoz-Galván's work include DNA Repair Mechanisms (7 papers), Cancer Cells and Metastasis (6 papers) and Peptidase Inhibition and Analysis (5 papers). Sandra Muñoz-Galván is often cited by papers focused on DNA Repair Mechanisms (7 papers), Cancer Cells and Metastasis (6 papers) and Peptidase Inhibition and Analysis (5 papers). Sandra Muñoz-Galván collaborates with scholars based in Spain, United States and United Kingdom. Sandra Muñoz-Galván's co-authors include Amancio Carnero, Manuel P. Jiménez-García, Marco Pérez, Andrés Aguilera, Daniel Otero-Albiol, Antonio Lucena-Cacace, Eva M. Verdugo‐Sivianes, Sonia Jimeno, Purificación Estévez-García and Blanca Felipe‐Abrio and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sandra Muñoz-Galván

38 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Muñoz-Galván Spain 18 661 387 215 132 103 40 1.0k
Víctor J. Sánchez‐Arévalo Lobo Spain 14 693 1.0× 311 0.8× 152 0.7× 61 0.5× 44 0.4× 23 887
Dun Li China 11 840 1.3× 636 1.6× 248 1.2× 127 1.0× 81 0.8× 26 1.1k
Sanjeev Das India 19 668 1.0× 415 1.1× 268 1.2× 70 0.5× 52 0.5× 36 1.1k
Liling Wan United States 13 1.1k 1.6× 533 1.4× 323 1.5× 75 0.6× 112 1.1× 19 1.6k
Weiqun Mao United States 20 546 0.8× 310 0.8× 217 1.0× 87 0.7× 74 0.7× 33 896
Michaela Medová Switzerland 20 650 1.0× 322 0.8× 189 0.9× 98 0.7× 197 1.9× 51 1.0k
Yi Sang China 19 885 1.3× 220 0.6× 433 2.0× 51 0.4× 108 1.0× 44 1.1k
Arifumi Iwamaru Japan 9 514 0.8× 314 0.8× 200 0.9× 55 0.4× 63 0.6× 19 893
Kelly A. Avery‐Kiejda Australia 21 882 1.3× 494 1.3× 410 1.9× 170 1.3× 93 0.9× 50 1.3k
Sumaiyah K. Rehman United States 8 740 1.1× 386 1.0× 420 2.0× 87 0.7× 72 0.7× 12 1.1k

Countries citing papers authored by Sandra Muñoz-Galván

Since Specialization
Citations

This map shows the geographic impact of Sandra Muñoz-Galván's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Muñoz-Galván with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Muñoz-Galván more than expected).

Fields of papers citing papers by Sandra Muñoz-Galván

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Muñoz-Galván. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Muñoz-Galván. The network helps show where Sandra Muñoz-Galván may publish in the future.

Co-authorship network of co-authors of Sandra Muñoz-Galván

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Muñoz-Galván. A scholar is included among the top collaborators of Sandra Muñoz-Galván based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Muñoz-Galván. Sandra Muñoz-Galván is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xingyun, Mara Artibani, Aneesh Aggarwal, et al.. (2025). 3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline. Advanced Healthcare Materials. 14(14). e2404072–e2404072. 1 indexed citations
2.
Estévez-García, Purificación, et al.. (2024). Clinical and molecular features of platinum resistance in ovarian cancer. Critical Reviews in Oncology/Hematology. 201. 104434–104434. 11 indexed citations
3.
Otero-Albiol, Daniel, José M. Santos-Pereira, Antonio Lucena-Cacace, et al.. (2024). Hypoxia-induced immortalization of primary cells depends on Tfcp2L1 expression. Cell Death and Disease. 15(2). 177–177. 1 indexed citations
4.
Muñoz-Galván, Sandra, et al.. (2024). Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors. Journal of Experimental & Clinical Cancer Research. 43(1). 57–57. 11 indexed citations
5.
Blanco, José Ramón, et al.. (2022). The circadian rhythm of viruses and its implications on susceptibility to infection. Expert Review of Anti-infective Therapy. 20(8). 1109–1117. 4 indexed citations
6.
Muñoz-Galván, Sandra & Amancio Carnero. (2021). Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer. Cancers. 13(16). 4029–4029. 15 indexed citations
7.
Quintanal-Villalonga, Àlvaro, Irene Ferrer, Elizabeth Guruceaga, et al.. (2020). FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy. EBioMedicine. 53. 102683–102683. 17 indexed citations
8.
Muñoz-Galván, Sandra & Amancio Carnero. (2020). Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer. Cells. 9(6). 1402–1402. 59 indexed citations
9.
Muñoz-Galván, Sandra, et al.. (2020). PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208. Cells. 9(5). 1071–1071. 9 indexed citations
10.
Pérez, Marco, José Manuel García-Heredia, Blanca Felipe‐Abrio, et al.. (2020). Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment. Signal Transduction and Targeted Therapy. 5(1). 195–195. 13 indexed citations
12.
Muñoz-Galván, Sandra, Blanca Felipe‐Abrio, Eva M. Verdugo‐Sivianes, et al.. (2019). New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools. Journal of Experimental & Clinical Cancer Research. 38(1). 234–234. 34 indexed citations
13.
Lucena-Cacace, Antonio, Daniel Otero-Albiol, Manuel P. Jiménez-García, Sandra Muñoz-Galván, & Amancio Carnero. (2017). NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP. Clinical Cancer Research. 24(5). 1202–1215. 128 indexed citations
14.
Verdugo‐Sivianes, Eva M., Lola E. Navas, Sonia Molina‐Pinelo, et al.. (2017). Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer. Oncotarget. 8(62). 105196–105210. 16 indexed citations
15.
Muñoz-Galván, Sandra, Marı́a Garcı́a-Rubio, José F. Ruiz, et al.. (2017). A new role for Rrm3 in repair of replication-born DNA breakage by sister chromatid recombination. PLoS Genetics. 13(5). e1006781–e1006781. 16 indexed citations
16.
Muñoz-Galván, Sandra, Gabriel Gutiérrez, Marco Pérez, & Amancio Carnero. (2015). MAP17 (PDZKIP1) Expression Determines Sensitivity to the Proteasomal Inhibitor Bortezomib by Preventing Cytoprotective Autophagy and NFκB Activation in Breast Cancer. Molecular Cancer Therapeutics. 14(6). 1454–1465. 23 indexed citations
17.
Estévez-García, Purificación, Sonia Molina‐Pinelo, Sandra Muñoz-Galván, et al.. (2013). Spinophilin Loss Correlates with Poor Patient Prognosis in Advanced Stages of Colon Carcinoma. Clinical Cancer Research. 19(14). 3925–3935. 15 indexed citations
18.
Blanco‐Aparicio, Carmen, et al.. (2013). Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia. PLoS ONE. 8(4). e60277–e60277. 26 indexed citations
19.
Muñoz-Galván, Sandra, Ana López-Saavedra, Stephen P. Jackson, et al.. (2012). Competing roles of DNA end resection and non-homologous end joining functions in the repair of replication-born double-strand breaks by sister-chromatid recombination. Nucleic Acids Research. 41(3). 1669–1683. 14 indexed citations
20.
Hohl, Marcel, Youngho Kwon, Sandra Muñoz-Galván, et al.. (2011). The Rad50 coiled-coil domain is indispensable for Mre11 complex functions. Nature Structural & Molecular Biology. 18(10). 1124–1131. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026